Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
10.78
-0.25 (-2.27%)
Jun 20, 2025, 10:40 AM - Market open
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $393.44 million as of June 20, 2025.
Market Cap
393.44M
Enterprise Value
125.03M
1-Year Change
n/a
Ranking
Category
Stock Price
10.78
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has decreased from $601.40M to $393.44M, a decrease of -34.58%. That is a compound annual growth rate of -33.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 402.57M | -37.96% |
| Dec 31, 2024 | 648.87M | 7.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.75B |
| Johnson & Johnson | 362.67B |
| Novo Nordisk | 333.14B |
| AbbVie | 327.65B |
| UnitedHealth Group | 278.67B |
| Abbott Laboratories | 230.37B |
| Novartis AG | 227.73B |
| AstraZeneca | 219.65B |